Michael Best Attorney Lisa L. Mueller will present the topic "Maximizing the Biosimilar Space: Understanding the FDA’s Biosimilars Approval Process and Utilizing the US Patent and Trademark Office’s Procedures" at the 4th International Conference and Exhibition on Biologics and Biolsimilars, which will take place October 26-28 in Baltimore, Maryland.
Biosimilars is a global annual event. This Biosimilars 2015 brings together scientists, researchers and CROs from around the world. Biologics are a highly-effective class of medicines that are based on naturally occurring proteins and produced using living cells. Many biologics are produced using recombinant DNA technology.
To view additional information on the conference and to register, click here.